| Literature DB >> 29423529 |
Boxiao Wang1, Stephanie Thurmond2, Rong Hai3, Jikui Song4.
Abstract
Zika virus (ZIKV) belongs to the positive-sense single-stranded RNA-containing Flaviviridae family. Its recent outbreak and association with human diseases (e.g. neurological disorders) have raised global health concerns, and an urgency to develop a therapeutic strategy against ZIKV infection. However, there is no currently approved antiviral against ZIKV. Here we present a comprehensive overview on recent progress in structure-function investigation of ZIKV NS5 protein, the largest non-structural protein of ZIKV, which is responsible for replication of the viral genome, RNA capping and suppression of host interferon responses. Structural comparison of the N-terminal methyltransferase domain and C-terminal RNA-dependent RNA polymerase domain of ZIKV NS5 with their counterparts from related viruses provides mechanistic insights into ZIKV NS5-mediated RNA replication, and identifies residues critical for its enzymatic activities. Finally, a collection of recently identified small molecule inhibitors against ZIKV NS5 or its closely related flavivirus homologues are also discussed.Entities:
Keywords: Antiviral inhibitors; Drug discovery; Flavivirus; Non-structural protein 5; Pathogen–host interaction; RNA capping; Viral replication
Mesh:
Substances:
Year: 2018 PMID: 29423529 PMCID: PMC5911220 DOI: 10.1007/s00018-018-2751-x
Source DB: PubMed Journal: Cell Mol Life Sci ISSN: 1420-682X Impact factor: 9.261